Patents by Inventor Jafar Ai

Jafar Ai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230226114
    Abstract: A composition including endometrial, especially mesenchymal stem cells (EnMSC), for use in a method for the treatment of poor ovarian response and a method for banking endometrial, especially mesenchymal, stem cells.
    Type: Application
    Filed: April 2, 2021
    Publication date: July 20, 2023
    Inventors: Mohammad Mehdi AHMAD AKHONDI, Jafar AI, Somayeh EBRAHIMI BAROUGH, Zohreh MOHAMMADI
  • Publication number: 20140370515
    Abstract: The various embodiments herein provide a method of co-culturing human endometrial stem cells and rat embryonic tooth bud cells to obtain ameloblast cells. The human endometrial stem cells are isolated from human females between the ages of 18-40 and cultured. The hEnSCs are identified using flowcytometry. The rat embryonic tooth bud cells are isolated from rat embryos and cultured. After the hEnSCs and rat embryonic tooth bud cells reach a desired level of cell growth, the hEnSCs are transferred to culture plate inserts and the rat embryonic tooth bud cells are transferred to a culture plate. The hEnSCs and rat embryonic tooth bud cells are co-cultured to obtain ameloblast cells. Immunocytochemical analysis is used to characterize the differentiated ameloblast cells. Quantitative real time PCR (qRT-PCR) is used to detect the presence of Ameloblastin, Amelogenin, Amelotin and Cytokeratin 14 proteins in differentiated ameloblast cells.
    Type: Application
    Filed: September 3, 2014
    Publication date: December 18, 2014
    Inventors: Jafar Ai, Naghmeh Bahrami, Azadeh Babaee, Saeed Heydari, Mina Jafar abadi, Reza Rouzafzoun, Mohamah Hosein Asadi, Mohamad Tavangar, Amir Amani
  • Publication number: 20140356410
    Abstract: The embodiments herein provide a biodegradable and biocompatible T-plate nano-composite implant with stem cells for treating and repairing broken bones, damaged tissues and torn ligaments. The implant comprises a polymeric matrix part comprising poly lactic glycolic acids (PLGA), a bioceramic part comprising hydroxyapatite (HAp) nanoparticles and an endometrial stem cell. The PLGA and HAp nanoparticles act as a matrix and reinforcing agents respectively. A method is provided for synthesizing the T-plate implant. The method comprises synthesizing hydroxyapatite (HAp) nanoparticles, poly lactic glycolic acids (PLGA) and HAp nano composite implant. The casting of the poly lactic glycolic acids (PLGA) and HAp nano composite are done in a mold to obtain a T-plate nano composite. An endometrial stem cell from an epithelial cell lining from uterus is isolated and cultured. The endometrial stem cells are implanted on the nano-composite implant.
    Type: Application
    Filed: June 10, 2014
    Publication date: December 4, 2014
    Inventors: Jafar Ai, Nastaran Elyasi far, Mahmoud Azami, Naghmeh Bahrami, Shima Tavakol